Figure 5.
Figure 5. PFS for chemosensitive patients with relapsed versus primary refractory disease. Kaplan-Meier curves of PFS for 150 patients with DLBCL, stratified by relapsed (n = 83) versus primary refractory (n = 67) status at time of second-line therapy.

PFS for chemosensitive patients with relapsed versus primary refractory disease. Kaplan-Meier curves of PFS for 150 patients with DLBCL, stratified by relapsed (n = 83) versus primary refractory (n = 67) status at time of second-line therapy.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal